EXHIBIT 9.1
PORTFOLIO LICENSE AGREEMENT
This Agreement, dated as of January 3, 2018, is made by and between GKD
Index Partners LLC d/b/a Alerian, a Delaware limited liability company
("Licensor"), and Guggenheim Funds Distributor, LLC ("GFD" or "Licensee"), as
sponsor to the Alerian MLP Infrastructure & Income Portfolio (the "Trust").
RECITALS
A. GFD sponsors, underwrites, and distributes a wide array of unit
investment trusts, including the Trust.
B. Licensor has developed an Index (which includes without limitation
selection criteria and methodology) set forth in Schedule A (the "Index"), and
Licensor owns all rights in and to the Index and the proprietary data relating
to the Index (such rights, including without limitation, copyright, trademark,
and other proprietary rights and trade secrets, being hereinafter collectively
referred to as the "Intellectual Property").
C. Licensor uses in commerce and has trade name, trademark, and/or service
xxxx rights to the marks set forth in Schedule B (such rights are individually
and collectively referred to herein as the "Marks").
D. Licensee wishes to use the Index, Intellectual Property, and the Marks
in connection with the Trust.
The parties agree as follows:
1. Grant of License.
(a) Grant. Subject to the terms and conditions of this Agreement, Licensor
hereby grants to the Licensee a non-transferable (except as otherwise provided
herein) license to use and refer to the Licensor Marks, the Index, and the
Intellectual Property (i) in connection with the creation, issuance, sale,
marketing, and promotion of the Trust in order to indicate (x) that the
securities included in the Trust are determined through the use of the Index,
(y) the historical performance of the Index, and (z) that Licensor is the source
of the Index; (ii) as may otherwise be required by applicable laws, rules or
regulations, and court orders or under this Agreement; and (iii) in the name of
the Trust (the "License").
(b) Scope. Licensor agrees that no person or entity (including without
limitation, the Trust) other than the Licensee shall need to obtain a license
from Licensor with respect to the use of the Licensor Marks, Intellectual
Property, and Index in connection with the creation, issuance, sale, marketing,
and promotion of the Trust, and that Licensee has the right to sublicense the
License to the Trust or other appropriate party if necessary or helpful in
achieving the intent of this Agreement.
(c) Ownership and Retention of Rights. The Licensee acknowledges that the
Index and the Licensor Marks are the exclusive property of Licensor and that
Licensor has and retains all Intellectual Property rights therein. Except as
otherwise specifically provided herein, Licensor reserves all rights to the
Index and the Licensor Marks, and this Agreement shall not be construed to
transfer to the Licensee any ownership right to, or equity interest in, any of
the Index or the Licensor Marks, or in any Intellectual Property rights
pertaining thereto.
(d) Duty to Maintain. During the term of this Agreement, Licensor shall use
its best efforts to maintain in full force and effect U.S. federal registrations
for the Licensor Marks.
2. Term. The term of this Agreement shall commence as of the date set forth
above and shall remain in full force and effect until the termination of the
Trust.
3. Fees. As consideration for the license granted herein, GFD shall pay to
Licensor a license fee equal to seven basis points (0.07%) of the aggregate
daily liquidation value of transactional sales (specifically excluding fee-based
sales) made during the primary offering period of the Trust (the "License Fee").
The License Fee shall be paid on a one-time basis on or before the fifteenth
(15th) day of the second (2nd) month after the close of the primary offering
period. Licensor acknowledges that (a) GFD may at any time determine that it
does not wish to go forward with a primary offering of the Trust and, if it so
determines, GFD shall not be responsible for the payment of any License Fee
under this Agreement, (b) GFD may delay the Deposit Date in its discretion, and
(c) GFD has full authority to determine the length of any offering period, and
may shorten or lengthen such offering period for any reason in its sole
discretion.
4. Relationship of the Parties. This Agreement shall not be deemed to
create any partnership or joint venture between GFD and Licensor, and the
services provided by Licensor shall be as an independent contractor and not as
an employee or agent of GFD. Licensor shall have no authority whatsoever to bind
GFD on any agreement or obligation. Licensor agrees that it shall not hold
itself out as an employee or agent of GFD.
5. Confidentiality. A party may obtain proprietary, non-public information
concerning the other party during the term of this Agreement. Each party shall
keep such information confidential and shall not use such information in any
manner. In no event shall the following information be deemed a disclosing
party's proprietary, non-public information: (a) information that is or becomes
generally available to the public other than as a result of disclosure by the
receiving party; (b) information that was within the receiving party's
possession prior to its being furnished by the disclosing party; (c) information
that becomes available to the receiving party from a third party who is not, to
the receiving party's knowledge, bound by an obligation of confidentiality to
the disclosing party; and (d) information that is independently developed by the
receiving party without the receiving party violating its obligations under this
agreement. Notwithstanding the above, a receiving party may disclose the
disclosing party's confidential information to the receiving party's affiliates
and its and their respective employees, agents, advisors, directors, attorneys,
consultants, and officers (collectively, "Representatives"), provided, however,
(a) such Representatives are made aware of this Agreement and agree to comply
with the terms of this Agreement as if they were parties hereto and (b)
information contained in the Licensor's audited financials may only be disclosed
(i) to Licensee's employees and (ii) for the sole purpose of assessing
Licensor's viability as a going concern. Each party acknowledges that a breach
of this Section would cause permanent and irreparable damage for which money
damages would be an inadequate remedy. Therefore, each party shall be entitled
to seek equitable relief in the event of any breach of the provisions of this
Section in addition to all other remedies available at law or in equity.
6. Indemnification. Each party shall defend, indemnify, and hold harmless
the other party from any and all liabilities, losses, damages, costs, and
expenses (including reasonable attorneys' fees) which the other party suffers by
reason of any claims, demands, actions, or suits brought by a third party
arising from the other party's (a) failure to comply with this Agreement or (b)
breach of a representation or warranty contained in this Agreement.
7. Limitation of Liability. Neither party shall be liable to the other
party for any liabilities, damages, costs, and expenses except for those
resulting from the other party's breach of a representation or warranty
contained in this Agreement, gross negligence, or willful misfeasance.
Notwithstanding the above, in no event shall either party be liable to the other
party for any punitive, special, indirect, consequential, incidental, or similar
damages or losses, regardless of how such damages or losses arise. Nothing in
this paragraph is intended to limit a party's right to indemnification under
Section 6.
8. Representations and Warranties.
(a) GFD. GFD represents, warrants, and covenants that it is a limited
liability company duly formed, existing, and in good standing under the laws of
the State of Delaware, with full right, power, and authority to enter into and
perform this Agreement, and the execution and performance of this Agreement does
not conflict with or violate any agreement to which it is a party, any court
order to which it is subject, or its Articles of Incorporation or Bylaws.
(b) Licensor. Licensor represents, warrants, and covenants that it is a
limited liability company duly formed, existing, and in good standing under the
laws of the State of Delaware, with full right, power, and authority to enter
into and perform this Agreement, and the execution and performance of this
Agreement does not conflict with or violate any agreement to which it is a
party, any court order to which it is subject, or any of its organizational
documents. Licensor further represents, warrants, and covenants that (i) the
Index, Intellectual Property, and Licensor Marks are the exclusive property of
Licensor, (ii) neither the Index nor the Licensor Marks or the Intellectual
Property and the License granted pursuant to this Agreement infringes or
otherwise violates any third party's intellectual property rights or other
proprietary rights, and (iii) neither Licensor nor any if its officers,
directors, employees, members, or agents shall disclose in any manner any
non-public information concerning the Trust prior to the Trust's deposit date.
9. Miscellaneous.
(a) Governing Law. This Agreement shall be governed by and construed and
enforced in accordance with the laws of the State of Illinois without giving
effect to any conflict of laws principles.
(b) Arbitration. Except as to any matter as to which the parties may seek
equitable relief, any dispute arising out of this Agreement shall be settled by
arbitration in accordance with the Rules of the American Arbitration
Association. Any such arbitration shall be held in the city of Chicago, in the
State of Illinois. The arbitrator of any such controversy shall not have the
authority to modify or alter any express condition or provision of this
Agreement. Any arbitration award rendered under this Section shall be final and
binding, and judgment may be entered on the award in any court of competent
jurisdiction.
(c) Entire Agreement. This Agreement, including the Schedules hereto,
constitutes the entire agreement between the parties with respect to the subject
matter hereof and supersedes all prior oral or written agreements relating to
the subject matter hereof.
(d) Assignment. Licensor shall not assign any rights or delegate any
obligations under this Agreement without the prior written consent of GFD, which
consent shall not be unreasonably withheld. Any assignment in violation of this
provision shall be void. GFD may assign its rights and obligations under this
Agreement to any successor in interest to all or substantially all of GFD's
assets. This Agreement shall be binding upon the heirs, successors, legal
representatives, and permitted assigns of the parties.
(e) Counterparts. This Agreement may be executed in two or more
counterparts, each of which shall be deemed an original and all of which
together shall constitute one and the same instrument.
(f) Survival. The provisions of Sections 5, 6, 7, 9(a), 9(b), 9(d) and 9(f)
shall survive the termination of this Agreement.
[Signature Page Follows]
IN WITNESS WHEREOF, the parties have caused this Agreement to be executed
as of the date first set forth above.
GKD INDEX PARTNERS LLC, AS LICENSOR
By /s/ Xxxxx Xxxx
-----------------
Name: Xxxxx Xxxx
Title: President and CEO
GUGGENHEIM FUNDS DISTRIBUTOR, LLC, AS SPONSOR OF THE
TRUST
By /s/ Xxxxxx Xxxxxxxx
----------------------
Name: Xxxxxx Xxxxxxxx
Title: Managing Director
SCHEDULE A
THE INDEX
Index Methodology and Construction:
The Alerian Energy Infrastructure Capital Strength Select Index is a composite
of North American midstream, refining, and utility companies chosen for their
ownership of pipeline transportation assets, leverage profile, and above-market
dividend payments.
A constituent must (1) earn the majority of its cash flow from qualifying
midstream activities involving energy commodities, or (a) own at least 50% of
the general partner (GP) of a US publicly traded partnership and (b) earn the
majority of its cash flow from (i) petroleum refining or (ii) the retail
distribution of electricity and/or natural gas; (2) for non-GPs, (a) have a
credit rating from at least one of Xxxxx'x or S&P of at least Ba2 or BB,
respectively; and (b) not have a credit rating from either of Xxxxx'x or S&P
worse than Ba2 or BB, respectively; (3) have a cash indicative yield greater
than the weighted average of the S&P 500 on the data analysis date; and (4) not
be party to an announced transaction that will lead to a delisting of the
security. For the criterion related to credit rating, GPs may qualify on their
own merits or via their publicly traded affiliates. A non-constituent will only
be added to the index during the (a) quarterly rebalancing process if it meets
all criteria, or (b) special rebalancing process if it (i) is acquiring the
constituent that is being removed and (ii) meets all criteria. Constituents will
only be removed from the index for failing to meet criteria during the quarterly
rebalancing process.
Quarterly rebalancings occur on the third Friday of each March, June, September,
and December, and are effective at the open of the next trading day. In the
event that the major US and Canadian exchanges are closed on the third Friday of
March, June, September, or December, the rebalancing will take place after
market close on the immediately preceding trading day. Data relating to
constituent eligibility, additions, and deletions are analyzed as of 16:00 ET on
the last trading day of February, May, August, and November. The index shares of
each constituent are then calculated according to the system described below and
assigned after market close on the quarterly rebalancing date. Since index
shares are assigned based on prices on the last trading day of February, May,
August, and November, the weight of each constituent on the quarterly
rebalancing date may differ from its target weight due to market movements.
After market close on the last trading day of February, May, August, and
November, any non-GP is removed for redundancy if its GP remains among the
eligible securities. The mean indicative yield of the remaining securities is
calculated, as well as the standard deviation of the data set. Any security
whose indicative yield is greater than the mean plus two standard deviations is
deemed to have an outlier yield and removed. For each GP that is removed for
having an outlier yield, its LP is added back to the group of eligible
securities if (1) it was removed solely for redundancy and (2) it does not have
an outlier yield. The constituents are then assigned to either the Pass-Through
or Corporate group based on their tax election. The Pass-Through group is
assigned an index weight of 20%, and the Corporate group is assigned an index
weight of 80%. The mean indicative yield is calculated for each group. Each
security is assigned a factor value by subtracting the absolute value of the
difference between its indicative yield and the mean indicative yield for its
group from the mean indicative yield. Each security is assigned an index weight
by dividing its factor value by the sum of all factor values for the group and
multiplying by the group's total index weight.
SCHEDULE B
LICENSOR MARKS
Alerian
